Development of a Center for Personalized Cancer Care at a Regional Cancer Center

We report the feasibility of a tumor sequencing advisory board at a regional cancer center. Specimens were analyzed for approximately 2800 mutations in 50 genes. Outcomes of interest included tumor sequencing advisory board function and processes, timely discussion of results, and proportion of reports having potentially actionable mutations. NGS results were successfully generated for 15 patients, with median time from tissue processing to reporting of 11.6 days (range, 5 to 21 days), and presented at a biweekly multidisciplinary tumor sequencing advisory board.

Source: Journal of Molecular Diagnostics - August 30, 2015 Category: Pathology Authors: Brian R. Lane, Jeffrey Bissonnette, Tracy Waldherr, Deborah Ritz-Holland, Dave Chesla, Sandra L. Cottingham, Sheryl Alberta, Cong Liu, Amanda Bartenbaker Thompson, Carrie Graveel, Jeffrey P. MacKeigan, Sabrina L. Noyes, Judy Smith, Nehal Lakhani, Matthew Tags: Regular Article Source Type: research